Funding for this research was provided by:
National Institutes of Health (GM099827-06)
National Institute on Aging (RF1 AG055088)
Article History
Received: 22 September 2021
Accepted: 11 December 2021
First Online: 17 February 2022
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare they have no competing financial interest(s). SEB own shares in Bondwell Technologies, a company that commercializes materials composed of Ultrabithorax, a protein with intrinsically disordered regions.